Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash Flows From Operating Activities:
Net loss	$ (11,201)	$ (16,467)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	39,182	37,394
Amortization of debt issuance costs and discounts	1,481	1,542
Loss on early extinguishment and modification of debt	542
Deferred income tax benefit	(5,840)	(8,417)
Equity-based compensation	3,520	4,482
Other, including loss on sale or disposal of assets, net	5,594	3,221
Changes in assets and liabilities:
Accounts receivable	(8,453)	(1,361)
Inventories	(1,844)	(3,936)
Prepaid expenses and other current assets	(21,320)	(6,863)
Accounts payable and accrued expenses	13,473	(345)
Accrued salaries, wages and benefits	3,558	5,377
Deferred revenue	55,913	42,072
Other accrued liabilities	(2,641)	(1,276)
Right of use assets and operating lease liabilities	121	104
Other assets and liabilities	(639)	(5,231)
Net cash provided by operating activities	71,446	50,296
Cash Flows From Investing Activities:
Capital expenditures	(87,286)	(69,758)
Other investing activities	(74)
Net cash used in investing activities	(87,360)	(69,758)
Cash Flows From Financing Activities:
Repayments of long-term debt	(2,933)	(3,000)
Proceeds from draws on revolving credit facility		20,000
Repayments of revolving credit facility		(20,000)
Purchase of treasury stock	(16,898)
Payment of tax withholdings on equity-based compensation through shares withheld	(7,460)	(5,569)
Exercise of stock options	455	565
Debt issuance costs	(179)
Other financing activities	(281)	(93)
Net cash used in financing activities	(27,296)	(8,097)
Change in Cash and Cash Equivalents, including Restricted Cash	(43,210)	(27,559)
Cash and Cash Equivalents, including Restricted Cash—Beginning of period	246,922	82,320
Cash and Cash Equivalents, including Restricted Cash—End of period	203,712	54,761
Supplemental Disclosure of Noncash Investing and Financing Activities
Capital expenditures in accounts payable	57,556	$ 45,548
Treasury stock purchases not yet settled in other accrued liabilities	$ 3,264